Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus.

Diabetes Metab J · 2022 · PMC8831822 · PMID 34253010

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

5.9 [3.8 to 9.3], P =0.001); u-ACR did not exhibit a significant trend across the stages of hepatic fibrosis ( Fig. 2B ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.